BUY Cipla Ltd. — Jigar S Patel, Anand Rathi
byJigar S Patel, Anand RathiHorizon: NA (inferred 1–3 months)21 Sept 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·22 Sept · today
Wockhardt Share Price Today: 2.19% rise and sector view
NewsGoogle News·17 Sept · 5d ago
Kopran Ltd. Share Price Rises 8.83% Today
NewsGoogle News·15 Sept · 1w ago
Explained: Why Morgan Stanley has the second-lowest price target on the Street for this drugmaker
NewsCnbc-Tv18·4 Sept · 3w ago
Cipla announces exclusive US partnership with Qilu Pharma for keytruda biosimilar
NewsCnbc-Tv18·3 Sept · 3w ago
Anthem Biosciences Share Price Today: valuation and peers
NewsGoogle News·18 Sept · 4d ago
SYMBIOTEC Share Price News: price rise and valuation view
NewsGoogle News·18 Sept · 4d ago
Cipla Ltd is intimating shareholders and creditors about a notice regarding a Scheme of Amalgamation (by Absorption) of Inzpera Healthsciences Limited with Cipla Limited. The notice provides an opport
BSE · Company Update·3 Sept · 3w ago
US FDA classifies Cipla subsidiary’s New York facility inspection as ‘Voluntary Action Indicated’
NewsCnbc-Tv18·29 Aug · 3w ago
Cipla Pharma License Cancellation: FDA Withdraws Order After HC Raps It For Going "Overboard"
NewsNdtv-Profit·29 Aug · 3w ago
US Drug Tariff: 15 Pharma Stocks Likely to Be Impacted by Trump’s New Tariff Plan
NewsGoogle News·16 Sept · 6d ago
Cipla slips after Qilu Pembrolizumab deal; Morgan Stanley flags crowded field
NewsHbl·4 Sept · 3w ago
Cipla Pharma license cancellation: FDA withdraws order after Bombay HC raps it for going 'overboard'
NewsCnbc-Tv18·29 Aug · 3w ago
FDA Crackdown: Cipla Arm Loses Pune Drug Sales Licence For Storage Deficiencies, Illegal Ads
NewsNdtv-Profit·28 Aug · 4w ago
Cipla gets seven USFDA observations for Pithampur plant after follow-up inspection
NewsCnbc-Tv18·25 Aug · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.